Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Arch Dermatol Res ; 315(6): 1621-1629, 2023 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-36757438

RESUMO

Psoriasis is an inflammatory disease of the skin, characterized by erythematous plaques. It is rather common, affecting 2-4% of the population in western countries. Psoriasis' etiology encompasses both genetic and environmental factors. Evidence suggests that the latter reflect the importance of changes in the microbiome for developing the disease. Thus, it is hypothesized that gut microbiome manipulation may arise as a way of treating psoriasis. However, few trials assessed the use of probiotics in psoriasis, although promising results were detected in small studies. Our objective was to assess the efficacy of adjuvant probiotics (Lactobacillus rhamnosus) in treating plaque psoriasis patients. This was a randomized, parallel, placebo-controlled, double-blind trial with two arms: experimental (n = 50) and control (n = 53). Inclusion of subjects and data gathering lasted from November 2020 to August 2021. Subjects were consecutive plaque psoriasis patients under regular follow-up in the Dermatology unit of a university-affiliated, tertiary-referral hospital in São Paulo (Brazil). Eligibility criteria included being over 18 years old, having plaque psoriasis and not having other skin diseases, neoplasms nor systemic inflammatory diseases. Subjects received standard-of-care plus probiotics (Lactobacillus rhamnosus formula). Controls received standard-of-care plus placebo. Primary outcome was skin lesion improvement as assessed by psoriasis area of severity index (PASI) at six months. Secondary outcome was quality-of-life as assessed by dermatology life quality index (DLQI) at six months. Regarding within-group analyses, changes in both PASI and DLQI were non-significant for the experimental group (mean PASI decreased by 1.58, p = 0.105, and mean DLQI increased by 0.05, p = 0.873) and significant for controls (mean PASI decreased by 1.90, p = 0.019, and mean DLQI decreased by 3.33, p = 0.031). Between-group analyses returned non-significant results (p = 0.620). Our findings do not support the hypothesis that gut microbiome modulation via ingestion of Lactobacillus rhamnosus produces clinical improvement in psoriasis patients. Further research is encouraged.Trial registration: Retrospectively registered at the Brazilian Clinical Trials Registry (RBR-8js7t83) on 08/02/2022.


Assuntos
Lacticaseibacillus rhamnosus , Psoríase , Humanos , Adolescente , Brasil , Universidades , Psoríase/tratamento farmacológico , Qualidade de Vida , Encaminhamento e Consulta , Hospitais , Índice de Gravidade de Doença , Resultado do Tratamento , Método Duplo-Cego
4.
Rev. patol. trop ; 47(2): 111-115, jun. 2018. tab
Artigo em Inglês | LILACS | ID: biblio-913770

RESUMO

The presence of Toxocara canis third instar larvae in the cerebellum of Rattus norvegicus may alter rodent behavior and movement. In this study, we investigated whether the sex of the rodent affects the migration of larvae to the cerebellum. Thirty-six Rattus norvegicus specimens (18 males and 18 females) were infected with 300 T. canis eggs and were euthanized after 60 days. The cerebellum was removed and treated with 0.5% HCl to recover the T. canis larvae. The number of larvae recovered from male rodents was significantly higher than in females, suggesting that the sex of the animal influences larval migration to the cerebellum


Assuntos
Animais , Ratos , Ratos , Cerebelo , Toxocara canis , Larva
5.
An Bras Dermatol ; 93(1): 129-132, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29641715

RESUMO

Secondary syphilis can have different clinical presentations, with corymbiform rash as its rarest manifestation. The disease is characterized by a central papule surrounded by smaller ones. We report the case of a man who has sex with man with corymbiform syphilis. The patient was subsequently diagnosed with HIV infection, hepatitis B, non-gonococcal urethritis, as well as infection of the central nervous system by treponema. This case not only illustrates a rare presentation of secondary syphilis, but also demonstrates the importance of further investigation of sexually transmitted infections, particularly among at-risk patients.


Assuntos
Infecções Sexualmente Transmissíveis/diagnóstico , Sífilis/diagnóstico , Adulto , Antibacterianos/uso terapêutico , Infecções por HIV/complicações , Infecções por HIV/diagnóstico , Hepatite B/complicações , Hepatite B/diagnóstico , Humanos , Masculino , Pacientes Desistentes do Tratamento , Fatores de Risco , Infecções Sexualmente Transmissíveis/complicações , Infecções Sexualmente Transmissíveis/terapia , Sífilis/complicações , Sífilis/terapia , Uretrite/complicações , Uretrite/diagnóstico
6.
An. bras. dermatol ; 93(1): 129-132, Jan.-Feb. 2018. graf
Artigo em Inglês | LILACS | ID: biblio-887149

RESUMO

Abstract: Secondary syphilis can have different clinical presentations, with corymbiform rash as its rarest manifestation. The disease is characterized by a central papule surrounded by smaller ones. We report the case of a man who has sex with man with corymbiform syphilis. The patient was subsequently diagnosed with HIV infection, hepatitis B, non-gonococcal urethritis, as well as infection of the central nervous system by treponema. This case not only illustrates a rare presentation of secondary syphilis, but also demonstrates the importance of further investigation of sexually transmitted infections, particularly among at-risk patients.


Assuntos
Humanos , Masculino , Adulto , Sífilis/diagnóstico , Infecções Sexualmente Transmissíveis/diagnóstico , Pacientes Desistentes do Tratamento , Uretrite/complicações , Uretrite/diagnóstico , Sífilis/complicações , Sífilis/terapia , Infecções Sexualmente Transmissíveis/complicações , Infecções Sexualmente Transmissíveis/terapia , Infecções por HIV/complicações , Infecções por HIV/diagnóstico , Fatores de Risco , Hepatite B/complicações , Hepatite B/diagnóstico , Antibacterianos/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA